Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Active & Responsive
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
for
Graves' Disease, Graves Disease
Location: New York NY, Fort Lauderdale FL, Kissimmee FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07570316
Phase3, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Montreal, Winston-Salem NC,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07391657
Phase3, Recruiting
Active & Responsive
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Get alerts for new trials in your area by subscribing now
Active & Responsive
PAIRS: Friend-Based AISA Intervention
for
Sexual Violence, College Drinking, Behavioral Changes
Location: Buffalo NY
Sponsor: State University of New York at Buffalo
Sex: Female
Age: 18 - 24
Code: NCT07433270
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: Philadelphia PA, Rochester NY, Anderson SC,
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07481981
Phase3, Recruiting
Active & Responsive
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Stony Brook NY, New York NY, Montreal, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06535607
Phase2, Recruiting
Active & Responsive
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
for
Hyperphosphatemia,
Location: Orange CT, Middlebury CT, Ridgewood NY, Norfolk VA,
Sponsor: R1 Therapeutics
Sex: All
Age: 18+
Code: NCT06712654
Phase2, Recruiting
Active & Responsive
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
for
Spinal Cord Injury, Traumatic Spinal Cord Injury,
Location: Manhasset NY, The Bronx NY
Sponsor: Northwell Health
Sex: All
Age: 21 - 70+
Code: NCT07625332
Phase2, Phase3, Recruiting
Active & Responsive
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
for
Advanced Breast Cancer, Early Breast Cancer
Location: Westbury NY, The Bronx NY, New York NY, Amsterdam NY,
Sponsor: TerSera Therapeutics LLC
Sex: Female
Age: 18 - 55
Code: NCT07310420
Phase1, Recruiting
Active & Responsive
Regular Diet After Colorectal Surgery
for
Colorectal, Diet Habits, Surgery, Post-operative Care
Location: New York NY
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT07540845
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
for
Myopia
Location: Boston MA, New York NY, Columbus OH, Bloomington IN,
Sponsor: Ohio State University
Sex: All
Age: 6 - 11
Code: NCT07567040
Phase3, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: New Haven CT, Albany NY, Berkeley Heights NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase3, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase2, Phase3, Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, Greenville NC, Chicago IL, Minneota MN,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase3, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Stamford CT, The Bronx NY, Summit NJ, Miami FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase2, Recruiting
Active & Responsive
PrP-targeting siRNA Safety & Mechanism Study
for
Prion Disease
Location: Boston MA, New York NY, Cleveland OH, Nashville TN,
Sponsor: Broad Institute of MIT and Harvard
Sex: All
Age: 18+
Code: NCT07444580
Phase1, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: New York NY, Toronto, Pittsburgh PA, Cleveland OH,